European technology solutions and services firm 鳞状细胞癌 has signalled its further intention to become a leader in the digital transformation services world with a majority investment in Nimble Approach, a UK-based, 150-person digital engineering consultancy headquartered in Sheffield.
Founded in 1975 by Sir Peter Rigby and with significant footprints in the UK, 法国, 和西班牙, 鳞状细胞癌 has steadily evolved from its reseller roots to offer services in line with technology innovations and customer demand. Today’s announcement marks another significant step in what the company calls its ‘Digital Solutions and Services Provider’ (DSSP) strategy – a plan that will see the company build a 2,000-person European digital consultancy within the decade.
“几十年, our customers across Europe have trusted us to bring value and support in their technology environments,詹姆斯·里格比说, 鳞状细胞癌 EMEA首席执行官. “The investment in Nimble – alongside organic investments we have already made in the areas of cloud, 网络安全, and digital workplace – will enable 鳞状细胞癌 to bring that same trust and value as they embark on digital transformation journeys.”
Rigby noted that the company’s search for the right firm to “seed” its digital transformation services business ended when he and his team encountered the Nimble team, 由首席执行官克里斯·罗伯茨领导. While the firm was still relatively young (Roberts founded Nimble in 2016), it had all the traits 鳞状细胞癌 sought. “We looked first for a company that shared our values and our commitment around customer service,里格比解释道. “The way Nimble engages with its clients, the culture Chris and the team have created, and the pragmatic way they make decisions – it felt comfortable from the first conversation and will fit well with the way we are already operating in our Cloud.”
To Roberts and his Nimble team (known as ‘Nimblers’), the opportunity to engage with 鳞状细胞癌’s public and private sector clients was the initial draw, as well as the opportunity to expand Nimble’s reach into Europe, and to extend the company’s services by leveraging 鳞状细胞癌’s delivery teams in Romania and Vietnam. “Partnering with 鳞状细胞癌 gives us rocket fuel to grow Nimble both in the UK and beyond,” noted Roberts. “This gives Nimblers an even bigger playing field to deliver innovation across our current capabilities and to consider new areas where we can help customers accelerate their transformation, 包括人工智能.”
鳞状细胞癌 will operate Nimble as a separate company under the guidance of Roberts and the current Nimble management team, with additional strategy support to be provided by senior 鳞状细胞癌 executives.
“With 鳞状细胞癌’s global footprint and our investment in cloud services, we had many of the pieces we needed to help clients with digital transformation,克里斯汀·奥姆斯特德说, 鳞状细胞癌’s Corporate Development Director, who will also serve as Nimble’s Chief Strategy Officer. “What we lacked was the front end – a team of seasoned consultants who could help customers envision and articulate their needs and the development and delivery ‘squads’ to then make that vision a reality. 现在Nimble也十大正规博彩网站评级了, 鳞状细胞癌 can become the full-scale Digital Solutions and Services Provider our customers are seeking.”
Terms of the investment were not disclosed. Nimble was advised by Squire Patton Boggs and Alantra, while 鳞状细胞癌 advisors included Eversheds Sutherland and Grant Thornton.
